Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas

References

• Hunter T. Oncogenes and proto-oncogenes: How do they differ. INCI 1988; 73: 773–86
   Google Scholar
• Burgess A. Growth factors and oncogenes. Immunology Today 1985; 6: 107–10
   PubMedGoogle Scholar
• Loutenberger J. A., Schultz R. A., Garon C. F., Tsichlis P. N., Papas T. S. Molecular cloning of avian mvelocytomatosis virus (MC 29) transforming sequencies. Proc. Natl. Acad. Sci. USA 1981; 78: 1518–22
   PubMed Web of Science ®Google Scholar
• Eisenman R. N., Tachibana C. I., Abrams H. D., Hann S. R. V-myc and c-myc encoded proteins are associated with the nuclear matrix. Mol. Cell Biol. 1985; 5: 114–26
   PubMed Web of Science ®Google Scholar
• Evan G. I., Hancock D. C. Studies on the interaction of the human c-myc protein with cell nuclei: p-62 c-myc as a member of a discrete subset of nuclear proteins. Cell 1985; 43: 253–261
   PubMed Web of Science ®Google Scholar
• Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7837–41
   PubMed Web of Science ®Google Scholar
• Nishikura K., Ar-Rushdi A., Erikson J., Watt R., Rovera G., Croce C. M. Differential expression of the normal and of the translocated c-myc oncogenes in B cells. Proc. Natl. Acad. Sci. USA 1983; 80: 4822–6
   PubMed Web of Science ®Google Scholar
• Waldman T. A., Korsmeyer S. J., Backshi A., Arnold A., Kirsch I. R. Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-myc oncogene (NIH Conference). Ann. Int. Med. 1985; 102(4)497–510
   PubMed Web of Science ®Google Scholar
• Croce C. M., Erikson J., Ar-Ruschdi A., Aden D., Nishikura K. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 1984; 81: 3170–4
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R., Croce C. M. Human c-mm oncogene is located in the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7824–7
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Martinotti S., Gallo R. Translocation and rearrangements of the c-myc oncogenes locus in human undifferentiated B-cell lymphomas (Report). Science 1983; 219: 963–7
   PubMed Web of Science ®Google Scholar
• Hamlyn P. H., Rabbits T. H. Translocation joins c-myc and immunoglobulin VI genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene. Nature 1983; 304: 135–9
   PubMed Web of Science ®Google Scholar
• Erikson J., Finger L., Sun L., Ar-Rushdi A., Nishikura K., Minowada J., Finan J., Emanuel B. S., Nowell P. C., Croce C. M. Deregulation of c-myc by translocation of the a-locus of the T-cell receptor in T cell leukemias. Science 1986; 232: 884–6
   PubMed Web of Science ®Google Scholar
• Erikson J., Ar-Rushdi A., Drwinga H. L., Nowell P. C., Croce C. M. Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1983; 80: 820–4
   PubMed Web of Science ®Google Scholar
• Collins S., Grondine M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature 1982; 298: 679–81
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Wong-Staal F., Gallo R. C. Onc gene amplification in pro myelocytic leukemia cell line HL60 and primary leukemic cells of the same patient. Nature 1982; 299: 61–3
   PubMed Web of Science ®Google Scholar
• Selten G., Cuyper H. T., Zijlstra M., Melief C., Berns A. Involvement of c-myc in MuLV induced T cell lymphomas in mice frequency and mechanisms of activation. EMBO Journal 1984; 3(13)3215–22
   PubMed Web of Science ®Google Scholar
• Janowski M. J., Nuyten J. M. Une minorite des lymphomes thymiques induits chez le rat par un virus des radio-leukosemurines, presente une insertion a proximite de c-myc, et une majorite un nouvel ARN polyadenyle non viral. C. R. Soc. Biol. 1987; 181: 55–61
   PubMedGoogle Scholar
• Reicin A., Yang J. Q., Marcu K. B., Fleissner E., Koehne C. F., O'Donnell P. V. Deregulation of the c-myc oncogene in virus induced thymic lymphomas of AKR/J mice (Notes). Mol. Cell Biol. 1986; 6(11)4088–92
   PubMed Web of Science ®Google Scholar
• Steffen D. Pro viruses are adjacent to c-myc in some murine leukemia virus induced lymphomas. Proc. Natl. Acad. Sci. USA 1984; 81: 2097–2101
   PubMed Web of Science ®Google Scholar
• Jones D. J., Ghosh A. K., Moore M., Schofield P. F. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. Br. J. Cancer 1987; 56: 779–83
   PubMed Web of Science ®Google Scholar
• Little C. D., Nau M. M., Carney D. N., Gardor A. F., Minna J. R. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194–6
   PubMed Web of Science ®Google Scholar
• Shihiya M., Yokota J., Ueyama Y. Amplification and expression of a cellular oncogene (c-myc) in human adenocarcinoma cells. Mol. Cell Biol. 1985; 5: 414–8
   PubMed Web of Science ®Google Scholar
• Papamichalis G., Francia K., Karachaliou F. E., Anastasiades O. T., Spandidos D. A. Expression of the c-myc oncoprotein in human metaplastic epithelial of fibrocystic disease. Anticancer Res. 1988; 8: 1217–22
   PubMed Web of Science ®Google Scholar
• Rothberg P. G., Erisman M. D., Diehl R. E., Rovigatti V. G., Astrin S. M. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Moll. Cell. Bid. 1984; 4: 1096–1103
   PubMed Web of Science ®Google Scholar
• Roy-Burman P., Devi G. B., Parker J. W. Differential expression of c-erb, c-myc and c-myb oncogene loci in human lymphomas and leukemias. Int. J. Cancer. 1983; 32: 185–91
   PubMed Web of Science ®Google Scholar
• Slamon D. J., De Keron J. B., Verma I. M., Mason D. Y. Expression of cellular oncogene in human malignancies. Science 1984; 224: 256
   PubMed Web of Science ®Google Scholar
• Mitani S., Sugawara I., Shiku H., Mori S. Expression of c-myc oncogene product and ras-family oncogene product in various human malignant lymphomas defined by immunohistochemical techniques. Cancer 1988; 62: 2085–93
   PubMed Web of Science ®Google Scholar
• Jack A. S., Kerr I. B., Evan Gi., Lee F. D. The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunochemistry. Br. J. Cancer 1986; 53: 713–9
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Evan G. I., Lewis Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 1985; 5: 3610–6
   PubMed Web of Science ®Google Scholar
• Spandidos D. A., Pintzas A., Kakkanas A., Yagnisis M., Mahera E., Patra E., Agnantis N. J. Elevated expression of the c-myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer. Res. 1987; 7: 1299–1304
   PubMed Web of Science ®Google Scholar
• Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375–86
   Web of Science ®Google Scholar
• Kothman K. J., Boice J. D. Epidemiological analysis with a programmable calculator. US Govt. Print off, Washington, DC 1979, [DHEW Publication No (NIH) 79–1649] 1979
   Google Scholar
• Kelly K., Cahran B. H., Stiles C. D., Leder P. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet derived growth factor. Cell. 1983; 35: 603–10
   PubMed Web of Science ®Google Scholar
• Lennert K. Histopathology of non-Hodgkiin's lymphomas. Lymphomas of Low Grade Malignancy. Springer-Verlag, Berlin 1981; 25–71
   Google Scholar